Detailed Information
Cited 2 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Phase Ib-II neoadjuvant chemotherapy with docetaxel plus atezolizumab plus herceptin SC and pertuzumab (TAHP) for patients with HER2-positive stage II/III breast cancer (NeoPATH) (KCSG BR 18-23, NCT03991878)
- Authors
- Park, Y. H.; Im, S-A.; Sim, S. H.; Suh, K. J.; Kim, M. H.; Ahn, H. K.; Jeong, J. H.; Kim, J-Y.; Lee, D-W.; Ahn, J-H.; Chae, H.; Lee, K-H.; Kim, J. H.; Lee, K. S.; Sohn, J. H.; Jung, K. H.
- Issue Date
- Sep-2021
- Publisher
- ELSEVIER
- Citation
- ANNALS OF ONCOLOGY, v.32, pp.S412 - S412
- Journal Title
- ANNALS OF ONCOLOGY
- Volume
- 32
- Start Page
- S412
- End Page
- S412
- ISSN
- 0923-7534
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 의과대학 > 의학과 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- Ahn, Hee Kyung
- College of Medicine (Department of Medicine)